What Researchers Did
Researchers reviewed existing studies on using hyperbaric oxygen (HBO) therapy alongside standard treatments for glioma, a type of brain tumor.
What They Found
This is a narrative review of prior studies, not a new clinical trial, and it reports that HBO therapy is used as an add-on to surgery, radiotherapy, chemotherapy, and photodynamic therapy. It states that existing studies show HBO can inhibit the growth of tumor tissue when used as an adjuvant therapy. The review notes HBO is not licensed for cancer treatment, and it describes the treatment as lower in cost and accepted by patients. No specific patient numbers, ATA levels, session counts, or statistical results are given in the abstract.
What This Means for Canadian Patients
For people with glioma, this review suggests HBO therapy has been studied as a possible add-on alongside surgery, radiotherapy, or chemotherapy, not as a replacement for them. The abstract itself notes HBO is not licensed for use in cancer treatment, so any decision to add it would need to be made with a patient's treatment team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a narrative review rather than a controlled clinical trial, this summarizes existing literature without reporting patient numbers, treatment protocols, or statistical outcomes of its own.